Cited by 978BRCA gene mutations in cancerGenetic factors in colorectal cancerPARP inhibition in cancer therapy

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

The discovery of the first gene associated with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs. Much has been learned during the past decade about the genetic epidemiology of breast cancer, the ethnic distribution and clinical consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility. The ability to translate this knowledge into novel treatments, however, remains elusive.

Integrity signals

Registry

Crossref · 10.1038/nrc1431

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Self-citation
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citation
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citation
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,589
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399

Flagged first, then by citations

Show all 187 references

Sorted by citations

Items 801–900 of 978

The Role of ALDH1A3 in Normal and Transformed Mammary Gland Development
Cull, A. (2012) · QSpace (Queen's University Library) · Cited by 1
Oxaliplatin Compromised CDK1 Activity Sensitizes BRCA-Proficient Cancers to PARP Inhibition in Oxaliplatin Resistance Gastric CancerPreprint
Li, H., Wang, C., Lan, L., Wu, W., Evans, I. M., Ruiz, E. J., Yan, L., Zhang, H., Zhou, Z., Hu, Z., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-529788/v1 · Cited by 1
Hereditary Breast Cancer
Schmutzler, R. K. (2008) · Wiley eBooks · doi:10.1002/9783527627523.ch11 · Cited by 1
Analiza molekularna kompleksu genów MRE11/RAD50/NBS1 w rodzinach z agregacją zachorowań na raki piersi i/lub jajnika
Antoszewska, E. (2021) · doi:10.48745/ppm.5hvx-b085
ALTERAÇÕES NO NÚMERO DE CÓPIAS GENÔMICAS EM CARCINOMAS DE MAMA
Tavares, A. C. T. (2013) · Americanae (AECID Library)
Development of supervised and unsupervised pixel based classification methods for medical image segmentation
Κωστόπουλος, Σ. (2009) · doi:10.12681/eadd/17319
Systemtherapie bei BRCA1- und -2-positiven Mamma- und Ovarialkarzinomen
Schmutzler, R. K., & Schott, S. (2014) · Der Gynäkologe · doi:10.1007/s00129-014-3351-y
Information et participation de patients dans divers contextes de décision en cancérologie
Mancini, J. (2008)
The Design, Synthesis, and Evaluation of Novel DFG-out Allosteric Kinase Inhibitors
Dietrich, J. D. (2008) · UA Campus Repository (The University of Arizona)
The Role of BRCA1 Domains and Motifs in Tumor Suppression
Velkova, A. (2009) · Defense Technical Information Center (DTIC) · doi:10.21236/ada511277
Implications of BRCA1 mutations in basal-like breast cancer development and treatment
Gu, Y. (2015) · Työväentutkimus Vuosikirja
Genomic Instability and DNA Repair
Gagos, S. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap07.pub2
Análisis de la supervivencia de las mujeres con cáncer de mama precoz diagnosticadas en el complejo hospitalario de Orense. ¿la determinacion inmunohistoquimica de ki-67, bcl-2 y p53 en el tejido tumoral aporta informacion pronostica en estas pacientes?
Gómez, J. G. (2012) · doi:10.14201/gredos.121155
Investigação de Mutações no Gene BRCA1 em Famílias Brasileiras com Suspeita da Síndrome Hereditária do Câncer de Mama e/ou Ovário.
Cury, N. M. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2012.tde-14062012-134410
3 Role of Tumor Suppressor BARD1 in Apoptosis and Cancer
Jefford, C. E., Wu, J. Y., & Irminger‐Finger, I. (2005) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(05)80058-3
DNA Repair, Cancer and Cancer Therapy
Wang, M. (2011) · InTech eBooks · doi:10.5772/20855
X-linked Gene Expression Profiles by RNAi-Mediated BRCA1 Knockdown in MCF7 Cells
Song, M., Park, J., Ahn, H.-J., Ko, J.-J., Lee, S., & Cha, B. (2005) · Genomics & Informatics
The BRCA/Fanconi recombination pathway in C. elegans meiosis
Montemauri, P. (2009) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/3230
Factors Associated with Early Versus Late Development of Breast and Ovarian Cancer in BRCA1 and BRCA2 Positive Women
Pickarski, J. (2010) · Digital Commons-TMC (Texas Medical Center)
Genetic polymorphisms in breast cancer in relation to risk and prognosis
Bågeman, E. (2008) · Lund University Publications (Lund University)
ERBB4 mutations in cancer and amyotrophic lateral sclerosis
Kurppa, K. J. (2014) · UTUPub (University of Turku)
The Cancer Spectrum Related to Hereditary and Familial Breast and Ovarian Cancers
Pensabene, M., Gesuita, R., Capuano, I., Condello, C., Spagnoletti, I., Maio, E. D., Carle, F., Pepe, S., & Contegiacomo, A. (2009) · Springer eBooks · doi:10.1007/978-88-470-1095-6_10
Kernel Machine Methods for Risk Prediction with High Dimensional Data
Sinnott, J. A. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Avaliação da patogenicidade de mutações germinativas de significado desconhecido nos genes BRCA1 e BRCA2 em famílias portuguesas.
Santos, C. G. R. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/g1ph-4s91
The Role of EZH2 in Genomic Stability and Tumorigenesis in Breast Cancer
DuPrie, M. L. (2010) · Deep Blue (University of Michigan)
Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations
Magnusson, S. (2012) · Lund University Publications (Lund University)
The Impact of Prophylactic Salpingo-oophorectomy on Health in Women who carry a BRCA1 or BRCA2 Mutation
Finch, A. (2011) · TSpace (University of Toronto)
Hereditary Breast Cancer and Hereditary Non-Polyposis Colorectal Cancer: Description of Two Families, as the Examples of Classical Hereditary Predisposition to Cancers
Stembalska, A., Bednarczyk, D., & Sasiadek, M. M. (2009) · Polish Journal of Surgery · doi:10.2478/v10035-009-0077-y
The Basal Phenotype of BRCA1-Related Breast Cancer
Foulkes, W. D. (2006) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(06)80322-x
Self-citation
Treatment of hormone receptor negative breast cancer
Andreopoulou, E., & Hortobágyi, G. N. (2010) · Hot Topics in Oncology · doi:10.4147/hto-100707
ACCURACY OF THE BRCAPRO RISK ASSESSMENT MODEL IN MALES PRESENTING TO MD ANDERSON FOR BRCA TESTING
Garby, C., Arun, B., Jackson, M. S., Litton, J. K., Hashmi, S. A., Giordano, M. D., & Singletary, S. M. (2012) · Digital Commons-TMC (Texas Medical Center)
A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report
Salgado, J., Santisteban, M., GUTIÉRREZ, C., Gil, C., Robles, M., VIEDMA, A., & Patiño‐García, A. (2013) · Oncology Letters · doi:10.3892/ol.2013.1440
Étude du transcriptome des cellules non tumorales de l’épithélium de surface de l’ovaire des femmes porteuses d’une mutation des gènes BRCA1 et BRCA2
Abd-Rabbo, D. (2009) · doi:10.71781/29680
Breast Cancer Risk Gene Discovery: Opportunities and Challenges
Lesueur, F. (2015) · Current Genetic Medicine Reports · doi:10.1007/s40142-015-0066-x
Estudo de moléculas de adesão no câncer de mama bilateral
Iyeyasu, H. (2011) · doi:10.11606/t.5.2011.tde-18022011-144806
BIOSYNTHESIS OF microRNAs AND THEIR ROLE IN GENE EXPRESSION PROFILING IN BREAST CANCER
de Paula, L. B. (2011) · Revista da Universidade Vale do Rio Verde · doi:10.5892/ruvrv.2011.92.215228
Breast Cancer – Diagnosis and Treatment Prolonging Life: A Review
Kasina, S., Yadav, H. K., & Shivakumar, H. G. (2014) · Journal of cancer research updates · doi:10.6000/1929-2279.2014.03.04.4
MOLECULAR STRESS SIGNALING IN BREAST EPITHELIAL CELLS Characterization of the Regulation of the Breast Cancer Susceptibility Gene 1 (BRCA1) by Stress Signaling and Design of an Epidemiological Study Examining the Effect of Glucocorticoid Receptor Genetic Variants on Breast Cancer Risk
Antonova, L. (2007)
Prevention of Male Breast Cancer
Ouzounakis, P., Tsiligiri, M., Krepia, V., & Kourkouta, L. (2020) · DOAJ (DOAJ: Directory of Open Access Journals)
Analysis and characterization of chemo- and radiation therapy sensitizing strategies in tumours with focus on effects of phenothiazines on DNA damage response signalling
Zielinska-Chomej, K. (2015) · Figshare
Unclassified sequence variants (UVS) and genetic predisposition to cancer
Negură, L., Uhrhammer, N. A., Negură, A., Ungureanu, E., Carasevici, E., & Bignon, Y. (2010)
Development of a novel screen protocol for the identification of genes causing replication associated genomic instability in Schizosaccharomyces pombe
Jarvis, M. L. (2008) · QSpace (Queen's University Library)
New Trends of MRI in Breast Cancer Diagnosis
Vergnaghi, D., Trecate, G., & Manoukian, S. (2007) · Springer eBooks · doi:10.1007/978-3-540-36781-9_10
THE ROLE AND REGULATION of MITOCHONDRIAL DYNAMICS IN CISPLATIN RESISTANCE IN HUMAN GYNECOLOGIC CANCER CELLS
Kong, B. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-6589
The Role of BRCA1 and BRCA2 in Anticancer Drug Therapy
Shuen, A. Y., Reis-Filho, J. S., & Foulkes, W. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_6
Self-citation
Análise da expressão de HLA-G em carcinomas ductais infiltrantes mamários
Breginski, F. S. C. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Molecular targets for epithelial ovarian cancer
Suh, G. K., Hennessy, B. T., Verhaak, R. G. W., Yang, J.-Y., Mills, G. B., & Bast, R. C. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.055
Traumatic Arterial Spasm: (Report of a Case).
MacKenzie, W. C., & Breckenridge, W. G. (1945) · Europe PMC (PubMed Central)
DNA damage response activated by anti-cancer agent, irofulven
Wiltshire, T. D. (2007) · doi:10.33915/etd.2601
Individualized Novel Therapies for Patients with Tumor Suppressor Genes BRCA1 and BRCA2 Mutated Epithelial Ovarian Cancer
García-Nieto, S., Guillén‐Ponce, C., Alonso, C., Rodrguez-Soriano, M.-C., Pombo, M.-L., Earl, J., & Farghaly, S. A. (2016) · InTech eBooks · doi:10.5772/61938 · Cited by 1
Associations Between Genetic Polymorphisms in DNA Bypass Polymerases and Base Excision Repair Genes with the Risk of Breast Cancer
Family, L. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ex25-0g74
Knowing your patients' cancer family history saves lives
Ofer, A. A. (2013)
Personalizing Breast Cancer Therapy
Demonacos, C. (2013) · Global Journal of Breast Cancer Research · doi:10.14205/2309-4419.2013.01.01.2
Universidade Federal do Rio Grande do Sul Programa de Pós Graduação em Genética e Biologia Molecular
Giongo, A. (2007)
Disorders of DNA Repair and Metabolism
Plon, S. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00177-4
IMPLICA II ETICE ÎN COMUNICAREA REZULTATELOR TESTELOR MOLECULARE C !TRE FAMILIILE CU PREDISPOZI IE EREDITAR ! LA CANCER
Negur, A., Matei, M. C., Negur, L., Carasevici, E., Uhrhammer, N. A., Bignon, Y., & Azoic, D. (2010)
The Ras effector NORE1A forms a tumor suppressor complex with BRCA1.
Nelson, N. C. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2336
Correlation between protein and gene expression of HER-2 and topoisomerase 2a in infiltrative ductal breast carcinoma
Mitrovic, O. (2013) · doi:10.2298/bg20131101mitrovic
Knowing your patients' cancer family history saves lives The importance of cancer family history in everyday patient care
Ofer, A. A. (2013)
Global Proteome Survey -Transforming antibody-based affinity proteomics into a global discovery platform
Olsson, N. (2012) · Lund University Publications (Lund University)
Risk-Reducing Surgery for Breast Cancer Patients with BRCA Mutations
Kim, E., Kim, S., & Noh, D. (2016) · Springer eBooks · doi:10.1007/978-4-431-55552-0_1
SURVEY AND SUMMARY Homologous recombination and its regulation
Krejčí, L., Altmannová, V., Špı́rek, M., & Zhao, X. (2012)
Estudio sobre funciones específicas de proteínas MAGE-I y su relevancia en oncología
de Toledo, M. F. P. (2015) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Biomarkers of Oxidative Stress as Predictors of Breast Cancer Risk in Women and Adolescent Girls
Brennan, L. A. (2016) · ProQuest Demo Repository · doi:10.7916/d8gt5ngp
The contribution of recurrent BRCA2 mutations in unselected French Canadian ovarian cancer cases
Dolman, L. I. (2014) · eScholarship@McGill (McGill) · doi:10.82308/55278
THE STROMAL ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN BREAST TUMOURIGENESIS
Skelhorne‐Gross, G. (2014) · QSpace (Queen's University Library)
Genetic predisposition to breast and/or ovarian cancer – focus on the candidate BARD1 gene
Klonowska, K., Ratajska, M., Wojciechowska, M., & Kozłowski, P. (2015) · Biotechnologia · doi:10.5114/bta.2014.54796
MRI and Screening
Rajan, S., & Dall, B. J. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-42563-4_3
Identification of Germline Alterations in the Mad-homology 2 (MH2) Domain of SMAD3 and SMAD4 In Breast Cancer Susceptibility
Tram, E. (2012) · TSpace (University of Toronto)
Estudo de letalidade sintética em células transformadas por papilomavírus humano (HPV).
Abjaude, W. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-15052017-144525
Relation between Mutation in BRCA1&2 Carriers and Histopathlogical Characteristics of Breast Cancer Patients in Erbil City
Hamad, G., Ali, S., & Jubrael, J. (2016) · Journal of Zankoy Sulaimani - Part A · doi:10.17656/jzs.10556
The Human Genome: Implications for the Understanding of Human Disease
Rivenbark, A. G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00006-8
Gendiagnostik bei hereditären Tumorerkrankungen
Grischke, E. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-31602-9.00008-5
Landscaping the cell surface proteome of breast cancer: Following pathways through organelles to the plasma membrane
Kurbasic, E. (2017) · Lund University Publications (Lund University)
Advancing Genetic Science and New Technologies
de Paor, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316412336.002
Ethical Issues, Legal Issues and Public Policy Concerns in a New Genomic Era
de Paor, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316412336.003
The Role of Luteal Phase Fallopian Tube Epithelium in High-grade Ovarian Serous Carcinoma
Tone, A. A. (2010) · TSpace (University of Toronto)
Breast Cancer Stem Cells: Tumourspheres and Implications for Therapy
Morrison, B. J. (2011) · Griffith Research Online · doi:10.25904/1912/1434
THE IMPACT OF HISTAMINE RECEPTOR 2 ANTAGONISTS ON BREAST CANCER DEVELOPMENT AND MONOCYTIC POPULATIONS
Vila, A. (2018) · DalSpace (Dalhousie University)
Multianalyte Detection of Breast Cancer by Fabrication of Hybridmicroarrays on Polymer-Based Microanalytical Devices
Wei, S. (2006) · doi:10.31390/gradschool_dissertations.1704
Studies of epigenetic instability in human normal and diseased vulva skin
Zhang, Z. (2006) · doi:10.31390/gradschool_theses.2909
The Human Genome:
Rivenbark, A. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374418-0.00006-2
Hereditary breast and ovarian cancer genetics: Genetic testing in Serbia
Krivokuća, A., & Brankovic-Magic, M. V. (2018) · Pirotski zbornik · doi:10.5937/pirotzbor1843115k
Novel loss‑of‑function mutation in BRCA2 gene identified in a Chinese female with a family history of ovarian cancer: A case report
Cui, Y., Wang, Y., Zhang, N., He, J., Huang, H., Liu, F., Wei, S., Dong, Q., Wu, J., Lin, K., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9950
Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance
Cochran, R. L. (2014)
WITHDRAWN: A novel insight of Asp193His mutation on epigenetic methyltransferase activity of human EZH2 protein: An in-silico approach
Gautam, N., Kaur, S., Kaur, K., & Kumar, N. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.01.004
Hereditary Breast Cancer in Selected Populations: Screening RECQL Gene in Ontario, Canada, and Exploring BRCA1/2 and PALB2 in the Caribbean
Ahmed, H. (2018) · TSpace (University of Toronto)
Identifizierung von Patientinnen und Patienten mit der hereditären Form des Mamma- und Ovarialkarzinoms mittels Next-Generation-Sequencing-(NGS)-Technologie
Smogavec, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7487
BRCA1 and 53BP1 Mediate Reprogramming Through DNA Repair Pathway Choice
Georgieva, D. (2019) · doi:10.7916/d8-8hx3-4x61
Expresión tumoral de BRCA1 y resultados clínicos en pacientes uruguayas diagnosticadas de cáncer de mama antes de los 40 años
Malvasio, S., Camejo, N., Matteo, C. D., Caserta, B., Artagaveytia, N., Castillo, C., Schiavone, A., Notejane, R., Alonso, I., & Delgado, L. B. (2020) · Revista Médica del Uruguay · doi:10.29193/rmu.36.1.6
Breast Cancer
Arrick, B. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10032-9
Selection for Decreased BRCA2 Functional Activity in Homo sapiens After Divergence from the Chimpanzee-Human Last Common AncestorPreprint
Huang, J., Zhong, Y., Makohon-Moore, A. P., White, T., Jasin, M., Norell, M. A., Wheeler, W. C., & Iacobuzio–Donahue, C. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384677
Genes de Predisposición al Cáncer de Mama
Orozco‐Hernández, J. P., Marín‐Medina, D. S., Martínez-Muñoz, M. A., & Martínez, J. W. (2018) · Memorias
Breast Cancer Stem Cells
da Silveira, G. G., Oliveira–Costa, J. P., & Ribeiro‐Silva, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_7
Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide
GaoMin, W., & Lin, L. (2011)
Salinomycin as a potential chemotherapeutic compound in cisplatin-resistant ovarian cancer: effects and mechanisms
Zhong, X. Y., Rolink, A. G., Lindberg, R. L. P., & Schibler, J. (2013)
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
Hurley (2011)
Circulating RANKL, Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Zaman, T. (2018) · TSpace (University of Toronto)
Herediter ve Ailesel Meme Kanserlerinin Aile Öyküsü ile Klinikopatolojik Özelliklerinin Karşılaştırılması; Tek Merkez Deneyimi
Özdemir, K., Yiğit, M., EYÜBOĞLU, Y., Urfalı, M., & Koçer, B. (2021) · Sakarya Medical Journal · doi:10.31832/smj.934186
Breast Cancer Recurrence and Survival
Russo, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-72815-1_2

Authors: Narod, S. A., & Foulkes, W. D.
Affiliations: Sunnybrook Health Science Centre (CA)
McGill University (CA)
Corresponding author: Narod, Steven A.
ORCID: Narod, Steven A.
Foulkes, William D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-09
Volume: 4
Issue: 9
Pages: 665-676
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1431
OpenAlex: W2091961739
Cited by: 967
References: 187
Citations by year: 2026: 13 · 2025: 29 · 2024: 30 · 2023: 37 · 2022: 36 · 2021: 40 · 2020: 30 · 2019: 31 · 2018: 33 · 2017: 35 · 2016: 38 · 2015: 53 · 2014: 38 · 2013: 43 · 2012: 59
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, genetic susceptibility, DNA repair, genetic epidemiology, breast cancer prevention, breast cancer treatment
MeSH terms: Breast Neoplasms, DNA Damage, DNA Repair, Female, Humans, Mutation, Molecular Epidemiology, Genes, BRCA1, Genetic Predisposition to Disease, Genes, BRCA2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2: 1994 and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks